209 related articles for article (PubMed ID: 25722013)
1. Epigenetic alterations in human parathyroid tumors.
Verdelli C; Forno I; Vaira V; Corbetta S
Endocrine; 2015 Jun; 49(2):324-32. PubMed ID: 25722013
[TBL] [Abstract][Full Text] [Related]
2. Alterations of DNA methylation in parathyroid tumors.
Guarnieri V; Muscarella LA; Verdelli C; Corbetta S
Mol Cell Endocrinol; 2018 Jul; 469():60-69. PubMed ID: 28501573
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Alterations in Parathyroid Cancers.
Verdelli C; Corbetta S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28157158
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
Westin G
J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
[TBL] [Abstract][Full Text] [Related]
6. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
[TBL] [Abstract][Full Text] [Related]
7. Histone Modification on Parathyroid Tumors: A Review of Epigenetics.
Conti de Freitas LC; Castilho RM; Squarize CH
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628190
[TBL] [Abstract][Full Text] [Related]
8. Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas.
Carling T; Du Y; Fang W; Correa P; Huang S
Surgery; 2003 Dec; 134(6):932-9; discussion 939-40. PubMed ID: 14668725
[TBL] [Abstract][Full Text] [Related]
9. Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.
Sulaiman L; Juhlin CC; Nilsson IL; Fotouhi O; Larsson C; Hashemi J
Epigenetics; 2013 Jun; 8(6):646-55. PubMed ID: 23764768
[TBL] [Abstract][Full Text] [Related]
10. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
Singh P; Bhadada SK; Dahiya D; Saikia UN; Arya AK; Sachdeva N; Kaur J; Behera A; Brandi ML; Rao SD
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4084-e4096. PubMed ID: 34077544
[TBL] [Abstract][Full Text] [Related]
11. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479
[TBL] [Abstract][Full Text] [Related]
13. The Oncosuppressors MEN1 and CDC73 Are Involved in lncRNA Deregulation in Human Parathyroid Tumors.
Morotti A; Forno I; Verdelli C; Guarnieri V; Cetani F; Terrasi A; Silipigni R; Guerneri S; Andrè V; Scillitani A; Vicentini L; Ferrero S; Corbetta S; Vaira V
J Bone Miner Res; 2020 Dec; 35(12):2423-2431. PubMed ID: 32780442
[TBL] [Abstract][Full Text] [Related]
14. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Svedlund J; Barazeghi E; Stålberg P; Hellman P; Åkerström G; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):231-9. PubMed ID: 24292603
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic processes in sporadic parathyroid neoplasms.
Silva-Figueroa AM; Perrier ND
Mol Cell Endocrinol; 2018 Jul; 469():54-59. PubMed ID: 28400272
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.
Singh P; Bhadada SK; Arya AK; Saikia UN; Sachdeva N; Dahiya D; Kaur J; Brandi ML; Rao SD
J Clin Endocrinol Metab; 2022 Jan; 107(2):e783-e792. PubMed ID: 34453169
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
Costa-Guda J; Arnold A
Mol Cell Endocrinol; 2014 Apr; 386(1-2):46-54. PubMed ID: 24035866
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma.
Hewitt KM; Sharma PK; Samowitz W; Hobbs M
Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):928-33. PubMed ID: 18217513
[TBL] [Abstract][Full Text] [Related]
19. Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?
Aurilia C; Donati S; Palmini G; Miglietta F; Falsetti I; Iantomasi T; Brandi ML
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638805
[TBL] [Abstract][Full Text] [Related]
20. RIZ1 and histone methylation status in pituitary adenomas.
Xue Y; Chen R; Du W; Yang F; Wei X
Tumour Biol; 2017 Jul; 39(7):1010428317711794. PubMed ID: 28718376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
